Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersPediatrics Physician in Torrance, CA
NPI: 1336324920Primary Practice Location
LAC/HARBOR-UCLA MED CENTER
1000 W Carson St, Torrance, CA
Primary Employer
Harbor - UCLA Medical Center
dhs.lacounty.gov
HQ Phone
Get M.D. Eduard's Phone Numberphone_androidMobile
Get M.D. Eduard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2007 - 2027
American Board of Pediatrics
Pediatrics
American Board of Pediatrics
Pediatric Hematology-Oncology
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Pediatric Hematology/Oncology
2008 - 2011
Loma Linda University Health Education Consortium
Residency • Pediatrics
2007 - 2008
Yerevan State Medical University
Medical School
Until 1997
Anti-GD2 immunoliposomes loaded with oxamate for neuroblastoma.
Authors: Panosyan, William S, Panosyan, Daniel E, Koster, Jan, Panosyan, Eduard H
Journal: Pediatr Res
Publication Date: 2023-02-14
High-dose chemotherapy with autologous hematopoietic stem-cell rescue for pediatric brain tumor patients: a single institution experience from UCLA.
Authors: Alan Ikeda, Theodore Moore
Publication Date: 2010-07-20
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Tipifarnib
Lead Sponsor: Children's Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, PROCEDURE: Bone Marrow Biopsy, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Dexamethasone, RADIATION: Radiation Therapy, DRUG: Cyclophosphamide, DRUG: Cytarabine, DRUG: Vincristine Sulfate, DRUG: Methotrexate, PROCEDURE: Computed Tomography, PROCEDURE: Bone Marrow Aspiration, DRUG: Mercaptopurine, DRUG: Calaspargase Pegol, DRUG: Prednisolone, DRUG: Thioguanine, DRUG: Doxorubicin Hydrochloride, BIOLOGICAL: Inotuzumab Ozogamicin, DRUG: Pegaspargase, DRUG: Leucovorin Calcium, DRUG: Daunorubicin Hydrochloride, PROCEDURE: Bone Scan
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, BIOLOGICAL: Pegfilgrastim, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, DRUG: Dacarbazine, DRUG: Brentuximab Vedotin, PROCEDURE: Computed Tomography, BIOLOGICAL: Filgrastim, DRUG: Vinblastine Sulfate, DRUG: Doxorubicin Hydrochloride
